Skip to content

Press

Press

Terumo Cardiovascular Group and CytoSorbents Announce CytoSorb Cardiac Surgery Partnership

“Our collaboration with CytoSorbents enables us to offer this innovative, easy-to-use blood purification therapy to address our customers’ most challenging cardiac cases,” stated Arik Anderson, President of Perfusion and Surgical Devices Division at Terumo. “CytoSorb integrates with the heart-lung machine platform, giving surgical teams, for the first time, the ability to safely reduce dangerous inflammatory mediators in real-time as they are being generated during cardiac surgery.”

read more »
Press

Award for intensive care physicians at the Emden Clinic

The therapy of severe blood poisoning – termed Sepsis – is one of the specialties of intensive care at the Klinikum Emden. The Department of Anaesthesiology and Intensive Care Medicine under the direction of chief physician Dr. med. Klaus Kogelmann has long been represented at international congresses with his own work and together with the German working group SepNet (Competence Network Sepsis). For example, at the 7th International Sepsis Congress in Weimar in September, a presentation on the subject of “Blood purification in sepsis” (Cytosorb) was presented.

read more »
GPR Clinic introduces new procedure for sepsis therapy
Press

GPR Clinic introduces new procedure for sepsis therapy

The Department of Anaesthesiology, Anesthesiological Intensive Care and Perioperative Pain Management under the direction of Privatdozent Dr. med. med. Gerd Albuszies, MBA in the GPR Clinic, is now using a new therapy method in the intensive care unit of the GPR Clinic, which is used in a massive inflammatory reaction of the body (inflammatory cytokine release) in sepsis.

read more »
In Bramsche new procedure against blood poisoning
Press

In Bramsche new procedure against blood poisoning

Blood poisoning is one of the leading causes of death in Germany. The Bramscher Niels Stensen clinics are now working as one of the first homes in the region with a new method that helps fight blood poisoning as early as possible and save human lives.

read more »
CytoSorbents Receives Renewal of CytoSorb® CE Mark Through May 2024 and Annual ISO 13485:2016 Certification Through September 2022
Press

CytoSorbents Receives Renewal of CytoSorb® CE Mark Through May 2024 and Annual ISO 13485:2016 Certification Through September 2022

Mr. Vincent Capponi, Chief Operating Officer of CytoSorbents stated, „I am happy to announce CytoSorbents successfully completed its CE Mark and ISO13485:2016 re-certification audits. These certificates cover CytoSorb and our new manufacturing facility commissioned in June 2018. The success of this renewal of the CE Mark and recent audit is a reflection of CytoSorbents‘ ongoing commitment to quality. I am very proud of our quality, manufacturing, and research teams that contributed to these accomplishments.“

read more »
CytoSorbents Expands CytoSorb Distribution in Latin America to Brazil, Colombia, and Costa Rica
Press

CytoSorbents Expands CytoSorb Distribution in Latin America to Brazil, Colombia, and Costa Rica

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, expands CytoSorb distribution to Brazil, Colombia and Costa Rica, with Contatti Medical, Service & Medical Colombia, and Nutricare Costa Rica, respectively.

read more »
6th International CytoSorb Users` Meeting
Event Review

6th International CytoSorb Users` Meeting

One day ahead of the 39th International Symposium of Intensive Care and Emergency Medicine (ISICEM), CytoSorbents invited for its 6th International CytoSorb Users Meeting at the Square Meeting Center in Brussels, Belgium.

read more »
5th German-speaking CytoSorb user meeting
Event Review

5th German-speaking CytoSorb user meeting

On the eve of the 18th DIVI 2018 in Leipzig, CytoSorbents invited to the 5th German-speaking CytoSorb user meeting. An excellent speaker panel presented in Leipzig new data and insights on the following topics …

read more »
Successful 5th International CytoSorb Users Meeting
Event Review

Successful 5th International CytoSorb Users Meeting

Just prior to the 38th ISICEM conference, CytoSorbents held its 5th International CytoSorb Users Meeting, relocating to the larger ISICEM conference center from the Hotel Marivaux in years past, to accommodate nearly 150 participants from the growing global CytoSorb community, including physicians, partners, and distributors.

read more »
News

CytoSorb Literature Database

During your daily work at the patients’ bedside or when doing research in preparation for a lecture or a publication, you would love to gather a broad overview of the available literature surrounding CytoSorb therapy.

read more »
News

Roger-Bone-Prize

The Roger-Bone-Prize for clinical sepsis research, selected by the German Sepsis Society, is awarded every year to young scientists from German speaking countries.

read more »

Help us direct you to the right information by selecting the option that best describes you:

You are trying to enter content on the international website of CytoSorbents Europe with a US IP address.

* I am aware that the content provided on this website is in accordance with the European CE label of CytoSorb and that the CytoSorb device has neither been cleared or approved by the FDA.

You are trying to enter our US website with a non-US IP address.

This website is only for healthcare professionals in the USA.

* I am aware that the content provided on this website is in accordance with the Emergency Use Authorization (EUA) for use in critically-ill COVID-19 patients with imminent or confirmed respiratory failure, in defined circumstances, issued by the American FDA and that this EUA differs from the CE label.

You are trying to enter our international website with a US IP address.

This website is only for healthcare professionals outside the USA.

* I am aware that the content provided on this website is in accordance with the European CE label of CytoSorb and that the CytoSorb device has neither been cleared or approved by the FDA.

This website is only for healthcare professionals outside the USA.

Help us direct you to the right information by selecting the option that best describes you: